Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/2008
11/27/2008US20080292626 Kinesin inhibitors
11/27/2008US20080292618 Intranuclear protein transduction through a nucleoside salvage pathway
11/27/2008US20080292601 Treatment of graft-versus-host disease with il-10 expressing cells
11/27/2008US20080292600 Treatment of graft-versus-host disease
11/27/2008US20080292590 Multiple Sclerosis; use of soluble interleukin (IL)-18R;
11/27/2008US20080292544 Modified Proteins, Designer Toxins, and Methods of Making Thereof
11/27/2008CA2687957A1 Pharmaceutical containing ppar.delta. agonist
11/27/2008CA2687633A1 Amino acid sequences directed against growth factor receptors and polypeptides comprising the same for the treatment of diseases and disorders associated with growth factors and their receptors
11/27/2008CA2687535A1 Phosphate-modified oligonucleotide analogs with enhanced immunostimulatory activity
11/27/2008CA2687523A1 Chimeric pufa polyketide synthase systems and uses thereof
11/27/2008CA2687415A1 Bicyclosulfonyl acid (bcsa) compounds and their use as therapeutic agents
11/27/2008CA2686485A1 Purinones and 1h-imidazopyridinones as pkc-theta inhibitors
11/27/2008CA2685222A1 Methods of reducing eosinophil levels
11/27/2008CA2684134A1 Method and apparatus for the delivery of polynucleotide vaccines to mammalian skin
11/26/2008EP1995246A1 Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient
11/26/2008EP1994941A2 Medicine containing at least one oxidised protein
11/26/2008EP1994940A1 Therapeutic use of a recombinant erythropoietin having high activity and reduced side effects
11/26/2008EP1994931A1 Prophylactic or therapeutic agent for allergic ophthalmic disease or allergic nasal disease comprising tricyclic triazolobenzoazepine derivative
11/26/2008EP1994159A1 Use of recombinant modified vaccinia virus ankara (mva) for the treatment of type 1 hypersensitivity in a living animal including humans
11/26/2008EP1994003A1 Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them .
11/26/2008EP1994002A1 Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them
11/26/2008EP1993610A2 Process for preparing water-soluble polyethylene glycol conjugates of macrolide immunosuppressants
11/26/2008EP1993574A2 Specific cd4+cd25+ regulatory t cells for haematopoietic cell transplantation and immune tolerance
11/26/2008EP1993564A1 Method and composition for treating allergic diseases
11/26/2008EP1993544A1 The use of beta-aminoalcohols for the treatment of inflammatory disorders and pain
11/26/2008EP1993530A2 Use of dha and ara in the preparation of a composition for regulating gene expression
11/26/2008EP1993525A1 The use of beta-aminoalcohols in the treatment of inflammatory disorders and pain
11/26/2008EP1515736B1 Compositions against inflammatory processes
11/26/2008EP1496914B1 (20S)-1alpha-HYDROXY-2alpha-METHYL AND 2beta-METHYL-19-NOR-VITAMIN D3 AND THEIR USES
11/26/2008EP1480595B1 Use of esters of long-chain fatty acids for treatment of autoimmune diseases
11/26/2008EP1473300B1 Pharmaceutical composition for the treatment of psoriasis and other skin diseases
11/26/2008EP1421070B1 New piperidinyl derivates as modulators of chemokine receptor activity
11/26/2008EP1414455B1 Isoquinoline inhibitors of p38
11/26/2008EP1286680B1 Seaweed supplement diet for enhancing immune response in mammals
11/26/2008EP1124953B1 New transcription factor of mhc class ii genes, substances capable of inhibiting this new transcription factor and medical uses of these substances
11/26/2008EP0865293B1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling
11/26/2008EP0821732B1 Altered polypeptides with increased half-life
11/26/2008EP0735893B1 Pan dr-binding peptides for enhancement of the immune response
11/26/2008EP0710135B1 Extracorporeal Affinity Adsorption Devices
11/26/2008CN101313063A Cancer-rejection antigen peptide derived from glypican-3 (GPC3) for use in HLA-A2-positive patient and pharmaceutical comprising the antigen
11/26/2008CN101313062A Cell populations having immunoregulatory activity, method for isolation and uses
11/26/2008CN101313061A Method of expanding double negative t cells
11/26/2008CN101312959A Novel thiophene derivatives
11/26/2008CN101312746A Preparation containing iron(iii)-complexes and redox substances
11/26/2008CN101311193A Complexes using recombined triple helix support as base
11/26/2008CN101311191A Method for preparing immune globulin against lymphocyte of human
11/26/2008CN101311190A Antigen epitope for exciting protective immunity against tubercle bacillus of human body and uses thereof
11/26/2008CN101311189A Antigen epitope for exciting protective immunity against tubercle bacillus of human body and uses thereof
11/26/2008CN101311165A Novel antihistaminic piperidine derivatives and intermediates for the preparation thereof
11/26/2008CN100436578C Modulation of the transcription of pro-inflammatory gene products
11/26/2008CN100436462C Reaction method of biological alkali, reaction product and use thereof
11/26/2008CN100436452C Pyrazole compounds useful as protein kinase inhibitors
11/26/2008CN100436449C Preparation of pharmaceutical salts of 4((z)-(4-bromophenyl)(ethoxyimino)methyl)-1'-((2,4-dimethyl-1-oxido-3-pyridinyl)carbonyl)-4'-methyl-1,4'bipiperidine as ccr5-antagonists for the treatment of aid
11/26/2008CN100436439C Dimeric isoflavones
11/26/2008CN100436438C 2-phenylpyran-4-one derivatives as selective cox-2 inhibitors
11/26/2008CN100435824C Detoxifying formulation containing astragalus root and greenbrier and preparation process thereof
11/26/2008CN100435789C Flavonoids used as anti-rejection agent
11/26/2008CN100435663C Health-care food with functions of improving immunocompetence and protecting damaged gastric mucosa and its preparing method
11/25/2008US7456286 Bicyclic heteroaromatic compounds as kinase inhibitors
11/25/2008US7456217 Administering N-(2,6-Dichlorobenzoyl)-4-(2,6-dimethoxy-4-methoxymethylphenyl)-L-phenylalanine ethyl ester for therapy of multiple sclerosis
11/25/2008US7456168 2-(pyridin-2-ylamino)-pyrido[2,3, d]pyrimidin-7-ones
11/25/2008US7456158 4-dedimethylaminotetracycline derivatives
11/25/2008US7456157 Modulate sphingosine-1-phosphate (S1P) receptors with fewer side effects; for example, 2-amino-5-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-2-methylpentylphosphonic acid monoester; prophylactic or therapeutic agents against rejection of organ transplants, skin grafts, rheumatoid arthritis, lupus
11/25/2008US7455855 Obtained by reacting polyalkylene glycol or a reactive derivative, a phospholipid and a drug with each other to form covalent bonds to form a delivery substance
11/25/2008US7455835 Administering soluble cytotoxic t-lymphocyte associated antigen (ctla4) molecule that binds a cell surface B7 molecule
11/25/2008CA2433032C Sustained release drug delivery devices with coated drug cores
11/25/2008CA2414146C Substituted benzamides for immune enhancement and for the treatment of cancer, infection and manic-depressive illness
11/25/2008CA2318579C Nitrogen-containing heterocyclic compounds and medicaments containing the compounds
11/20/2008WO2008141119A2 Modulators of cftr
11/20/2008WO2008140782A2 Compounds for enzyme inhibition
11/20/2008WO2008140421A2 Heterocycloalkyl substituted pyrimidine derivatives
11/20/2008WO2008140420A2 Pyrimidine derivatives
11/20/2008WO2008140419A2 Pyridyl substituted pyrimidine derivatives
11/20/2008WO2008140335A2 Methods of immune or hematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer, cancer symptoms, or the symptoms of cancer treatments
11/20/2008WO2008140251A2 Cyclooxygenase-2 inhibitors
11/20/2008WO2008140026A1 Novel leukotriene receptor antagonist
11/20/2008WO2008139243A1 Vm23 and vm24, two scorpion peptides that block human t-lymphocyte potassium channels (sub-type kv1.3) with high selectivity and decrease the in vivo dth-responses in rats
11/20/2008WO2008139202A1 Neutralizing monoclonal antibody against human dll4
11/20/2008WO2008138968A2 Dosage form comprising 10-[(3s)-1-azabicyclo[2.2.2]oct-3-ylmethyl]-10h-phenothiazine, provided in a form suitable for oral administration of a daily dose of 1 mg to 3 mg
11/20/2008WO2008138943A2 Prophylactic and therapeutic use of sirtuin inhibitors in tnf-alpha mediated pathologies
11/20/2008WO2008138920A1 Dihydroquinone and dihydronaphthridine inhibitors of jnk
11/20/2008WO2008138889A2 3, 6-disubstituted-imidazo [1, 2-b] pyridazines and 3, 5-disubstituted pyrazolo[1, 5-a] pyrimidines as phosphatidylinositol-3-kinase inhibitors
11/20/2008WO2008138184A1 Derivatives of pyrroloazacycles, the method of making them and the use thereof as inhibitors of protein kinases
11/20/2008WO2008138120A1 Avian influenza h5n1 hemagglutilin pseudotyped lentiviral vector system for rapid identification of antivirals and neutralizing polypeptides
11/20/2008WO2008115631A9 Plant-produced compositions for treating papillomavirus infection and related methods
11/20/2008WO2008100562A3 Indoleamine 2,3-dioxygenase, pd-1/pd-l pathways, and ctla4 pathways in the activation of regulatory t cells
11/20/2008US20080289055 Melanoma antigens and their use in diagnostic and therapeutic methods
11/20/2008US20080287532 Oxacyclopentene-2 derivatives
11/20/2008US20080287531 Preventive and/or Therapeutic Agent for Sleeping Disorder
11/20/2008US20080287530 Tripolide Lactone Ring Derivatives as Immunomodulators and Anticancer Agents
11/20/2008US20080287517 Pyrazole Derivatives as Cb1 Modulators
11/20/2008US20080287510 Novel compounds as cannabinoid receptor ligands
11/20/2008US20080287498 Optically active isomers of ketotifen and therapeutically active metabolites thereof
11/20/2008US20080287496 1-Oxo- and 1,3-dioxoisoindolines and method of reducing inflammatory cytokine levels
11/20/2008US20080287482 Production of Polyketides and Other Natural Products
11/20/2008US20080287468 Purine and imidazopyridine derivatives for immunosuppression
11/20/2008US20080287466 4-amino-2,3-disubstituted thieno [2,3,d]pyrimidines and pharmaceutical compositions thereof
11/20/2008US20080287444 Pyrazole compounds useful as protein kinase inhibitors
11/20/2008US20080287416 Organic Compounds
11/20/2008US20080287410 Pyrimidine derivatives useful as inhibitors of pkc-theta
1 ... 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 ... 1172